CGeneTech CGeneTech

CGeneTech

Dedicated to the development of innovative small molecule drugs
A rich pipeline of innovative medicines A rich pipeline of innovative medicines

A rich pipeline of innovative medicines

Covering a wide range of disease areas including glucose-lowering, anti-cancer and rare diseases
Developing innovative drugs with better efficacy Developing innovative drugs with better efficacy

Developing innovative drugs with better efficacy

Benefiting patients worldwide
imgboxbg
CGeneTech

CGeneTech (Suzhou, China) Co., Ltd. founded in Suzhou Industrial Park (SIP) in 2010, is dedicated to developing and commercializing innovative small molecule drugs for breakthrough therapies. 

 

Know Us

CGeneTech(Suzhou,China) Co., Ltd. is a biotechnology company in the commercialization stage, with its core product, Class 1 innovative drug Shenggliptin, on the market. The company was founded in Suzhou Industrial Park in 2010, with a core team with decades of experience in the entire lifecycle of international drugs, dedicated to the research and development and industrialization of high-quality and differentiated small molecule innovative drugs. With an integrated drug research and development technology platform and a diversified business perspective, the company has built a rich pipeline of innovative drugs covering hypoglycemic, anticancer, and autoimmune diseases.

Dedicated to the development, manufacture and marketing of small molecule innovative drugs

About
20+
Industry experience
About
3000
Laboratory
About
20Items
Patents granted

News

Company News  |  Media Reports

imgboxbg
imgboxbg
imgboxbg

Cooperation

We want to build long-term business relationships with customers from all over the world on a mutually beneficial basis!

Contact Us

Add:Room 101, Bld C11, 218 Xinghu Rd,Suzhou industrial Park,China, 215123

Tel: +86-512-62956960(Recruitment)

         +86-512-62956961(marketing)

Copyright © 2022  CGeneTech (Suzhou, China) Co., Ltd.  All rights reserved.    Powered by 300.cn  SEO